ROYSTON IVOR
Insider CIK 1026765 · BIOC Director · VIRX CEO & President, Director · MMRF Director · SNDX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2024-11-25 | 2024-11-27 | 25,219 | — | $0 | 50,438 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2024-11-25 | 2024-11-27 | 25,219 | — | $0 | 839,741 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2024-08-25 | 2024-09-12 | 25,219 | — | $0 | 75,657 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2024-08-25 | 2024-09-12 | 25,219 | — | $0 | 814,522 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2024-06-20 | 2024-06-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2024-05-25 | 2024-05-29 | 25,219 | — | $0 | 100,876 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2024-05-25 | 2024-05-29 | 25,219 | — | $0 | 789,303 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2024-02-25 | 2024-02-27 | 25,219 | — | $0 | 126,095 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2024-02-25 | 2024-02-27 | 25,219 | — | $0 | 764,084 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2023-11-25 | 2023-11-28 | 25,219 | — | $0 | 151,314 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2023-11-25 | 2023-11-28 | 25,219 | — | $0 | 738,865 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2023-08-25 | 2023-08-29 | 25,219 | — | $0 | 176,533 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2023-08-25 | 2023-08-29 | 25,219 | — | $0 | 713,646 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2023-06-08 | 2023-06-09 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2023-05-25 | 2023-05-26 | 25,219 | — | $0 | 201,752 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2023-05-25 | 2023-05-26 | 25,219 | — | $0 | 688,427 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2023-02-25 | 2023-02-28 | 25,219 | — | $0 | 226,971 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2023-02-25 | 2023-02-28 | 25,219 | — | $0 | 663,208 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2022-11-25 | 2022-11-29 | 25,219 | — | $0 | 252,190 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2022-11-25 | 2022-11-29 | 25,219 | — | $0 | 637,989 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | S Sale | 2022-08-26 | 2022-08-29 | 13,379 | $4.01 | $53.6K | 612,770 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2022-08-25 | 2022-08-29 | 25,219 | — | $0 | 277,409 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2022-08-25 | 2022-08-29 | 25,219 | — | $0 | 626,149 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2022-07-08 | 2022-09-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | S Sale | 2022-05-26 | 2022-05-27 | 13,162 | $1.90 | $25.0K | 600,930 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2022-05-25 | 2022-05-27 | 25,219 | — | $0 | 302,628 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2022-05-25 | 2022-05-27 | 25,219 | — | $0 | 614,092 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2022-03-17 | 2022-03-18 | 412,500 | — | $0 | 412,500 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | S Sale | 2022-02-28 | 2022-03-01 | 14,635 | $2.78 | $40.7K | 588,873 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2022-02-25 | 2022-03-01 | 25,219 | — | $0 | 327,847 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2022-02-25 | 2022-03-01 | 25,219 | — | $0 | 603,508 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise deriv | 2021-12-29 | 2021-12-30 | 7,000 | — | $0 | 60,800 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | M Exercise | 2021-12-29 | 2021-12-30 | 7,000 | $0.90 | $6.3K | 578,289 | SEC↗ |
| VIRX | S Sale | 2021-11-29 | 2021-11-29 | 15,833 | $4.82 | $76.3K | 571,289 | SEC↗ |
| VIRX | S Sale | 2021-11-26 | 2021-11-29 | 11,914 | $4.80 | $57.2K | 587,122 | SEC↗ |
| VIRX | M Exercise deriv | 2021-11-25 | 2021-11-29 | 50,437 | — | $0 | 353,066 | SEC↗ |
| VIRX | M Exercise | 2021-11-25 | 2021-11-29 | 50,437 | — | $0 | 599,036 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | P Buy | 2021-11-15 | 2021-11-15 | 8,000 | $5.56 | $44.5K | 548,599 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2021-07-16 | 2021-07-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VIRX Viracta Therapeutics, Inc. | A Award deriv | 2021-03-26 | 2021-03-30 | 441,993 | — | $0 | 441,993 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2020-06-05 | 2020-06-09 | 500 | — | $0 | 500 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2019-06-17 | 2019-06-19 | 500 | — | $0 | 500 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2019-04-30 | 2019-06-19 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2018-06-29 | 2018-07-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2017-05-31 | 2017-06-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2017-03-31 | 2017-04-03 | 4,166 | — | $0 | 4,166 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | D To issuer | 2017-03-20 | 2017-03-22 | 125,000 | $13.75 | $1.72M | 625,545 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | A Award deriv | 2016-10-31 | 2016-11-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| MMRF MMRGlobal, Inc. | A Award deriv | 2016-05-12 | 2016-05-16 | 1,000,000 | $0.02 | $20.0K | 1,000,000 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion deriv | 2016-03-08 | 2016-03-08 | 315,195 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion deriv | 2016-03-08 | 2016-03-08 | 198,931 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion deriv | 2016-03-08 | 2016-03-08 | 86,419 | — | $0 | 0 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | P Buy | 2016-03-08 | 2016-03-08 | 150,000 | $12.00 | $1.80M | 750,545 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion | 2016-03-08 | 2016-03-08 | 315,195 | — | $0 | 315,195 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion | 2016-03-08 | 2016-03-08 | 198,931 | — | $0 | 514,126 | SEC↗ |
| SNDX Syndax Pharmaceuticals Inc | C Conversion | 2016-03-08 | 2016-03-08 | 86,419 | — | $0 | 600,545 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2015-12-31 | 2016-01-04 | 12,500 | — | $0 | 12,500 | SEC↗ |
| BIOC BIOCEPT INC | M Exercise deriv | 2015-11-09 | 2015-11-10 | 9,285 | — | $0 | 0 | SEC↗ |
| BIOC BIOCEPT INC | M Exercise | 2015-11-09 | 2015-11-10 | 9,285 | — | $0 | 34,878 | SEC↗ |
| BIOC BIOCEPT INC | M Exercise deriv | 2015-05-24 | 2015-07-08 | 8,735 | — | $0 | 0 | SEC↗ |
| BIOC BIOCEPT INC | M Exercise | 2015-05-24 | 2015-07-08 | 8,735 | — | $0 | 25,593 | SEC↗ |
| MMRF MMRGlobal, Inc. | A Award | 2015-05-20 | 2015-05-22 | 10,000,000 | — | $0 | 11,810,558 | SEC↗ |
| BIOC BIOCEPT INC | P Buy | 2015-03-16 | 2017-03-29 | 5,667 | $8.76 | $49.6K | 17,294 | SEC↗ |
| BIOC BIOCEPT INC | P Buy deriv | 2015-02-13 | 2015-02-18 | 12,000 | — | $0 | 12,000 | SEC↗ |
| BIOC BIOCEPT INC | P Buy | 2015-02-13 | 2015-02-18 | 12,000 | $1.25 | $15.0K | 16,858 | SEC↗ |
| BIOC BIOCEPT INC | A Award deriv | 2014-02-13 | 2014-02-18 | 26,500 | — | $0 | 26,500 | SEC↗ |
| BIOC BIOCEPT INC | J Other deriv | 2014-02-10 | 2014-02-12 | 2,500 | — | $0 | 2,500 | SEC↗ |
| BIOC BIOCEPT INC | J Other deriv | 2014-02-10 | 2014-02-12 | 9,285 | — | $0 | 9,285 | SEC↗ |
| MMRF MMRGlobal, Inc. | A Award | 2013-12-31 | 2014-01-03 | 1,000,000 | $0.05 | $50.0K | 1,810,558 | SEC↗ |
| MMRF MMRGlobal, Inc. | A Award deriv | 2013-05-28 | 2013-05-29 | 1,050,000 | $0.08 | $84.0K | 1,050,000 | SEC↗ |
| MMRF MMRGlobal, Inc. | A Award | 2013-05-28 | 2013-05-29 | 500,000 | $0.08 | $40.0K | 810,558 | SEC↗ |